Literature DB >> 34856070

Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss.

Amelia J Hessheimer1,2,3, Gloria de la Rosa4, Mikel Gastaca5, Patricia Ruíz5, Alejandra Otero6, Manuel Gómez6, Felipe Alconchel7, Pablo Ramírez7, Andrea Bosca8, Rafael López-Andújar8,9, Lánder Atutxa10, Mario Royo-Villanova7, Belinda Sánchez11, Julio Santoyo11, Luís M Marín12, Miguel Á Gómez-Bravo12, Fernando Mosteiro6, María T Villegas Herrera13, Jesús Villar Del Moral13, Carolina González-Abos2, Bárbara Vidal14, Josefina López-Domínguez15, Laura Lladó15, José Roldán16, Iago Justo17, Carlos Jiménez17, Javier López-Monclús18, Víctor Sánchez-Turrión18, Gonzalo Rodríguez-Laíz19, Enrique Velasco Sánchez20, Jose Á López-Baena20, Mireia Caralt21, Ramón Charco21, Santiago Tomé22, Evaristo Varo22, Pablo Martí-Cruchaga23, Fernando Rotellar23, María A Varona24, Manuel Barrera24, Juan C Rodríguez-Sanjuan25, Javier Briceño26, Diego López27, Gerardo Blanco27, Javier Nuño28, David Pacheco29, Elisabeth Coll4, Beatriz Domínguez-Gil4, Constantino Fondevila1,2,3.   

Abstract

Postmortem normothermic regional perfusion (NRP) is a rising preservation strategy in controlled donation after circulatory determination of death (cDCD). Herein, we present results for cDCD liver transplants performed in Spain 2012-2019, with outcomes evaluated through December 31, 2020. Results were analyzed retrospectively and according to recovery technique (abdominal NRP [A-NRP] or standard rapid recovery [SRR]). During the study period, 545 cDCD liver transplants were performed with A-NRP and 258 with SRR. Median donor age was 59 years (interquartile range 49-67 years). Adjusted risk estimates were improved with A-NRP for overall biliary complications (OR 0.300, 95% CI 0.197-0.459, p < .001), ischemic type biliary lesions (OR 0.112, 95% CI 0.042-0.299, p < .001), graft loss (HR 0.371, 95% CI 0.267-0.516, p < .001), and patient death (HR 0.540, 95% CI 0.373-0.781, p = .001). Cold ischemia time (HR 1.004, 95% CI 1.001-1.007, p = .021) and re-transplantation indication (HR 9.552, 95% CI 3.519-25.930, p < .001) were significant independent predictors for graft loss among cDCD livers with A-NRP. While use of A-NRP helps overcome traditional limitations in cDCD liver transplantation, opportunity for improvement remains for cases with prolonged cold ischemia and/or technically complex recipients, indicating a potential role for complimentary ex situ perfusion preservation techniques.
© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; complication: surgical/technical; donors and donation: donation after circulatory determination of death (DCD); extracorporeal membrane oxygenation (ECMO); ischemia reperfusion injury (IRI); liver transplantation/hepatology; organ procurement and allocation

Mesh:

Year:  2021        PMID: 34856070     DOI: 10.1111/ajt.16899

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

1.  Comment on: a multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation.

Authors:  Christian Hobeika; Mickaël Lesurtel; François Cauchy
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

2.  Current practice of normothermic regional perfusion and machine perfusion in donation after circulatory death liver transplants in Italy.

Authors:  Riccardo De Carlis; Andrea Lauterio; Leonardo Centonze; Vincenzo Buscemi; Andrea Schlegel; Paolo Muiesan; Luciano De Carlis
Journal:  Updates Surg       Date:  2022-02-28

Review 3.  Normothermic Machine Perfusion-Improving the Supply of Transplantable Livers for High-Risk Recipients.

Authors:  Angus Hann; Anisa Nutu; George Clarke; Ishaan Patel; Dimitri Sneiders; Ye H Oo; Hermien Hartog; M Thamara P R Perera
Journal:  Transpl Int       Date:  2022-05-31       Impact factor: 3.842

4.  Normothermic Regional Perfusion and Hypothermic Oxygenated Machine Perfusion for Livers Donated After Controlled Circulatory Death With Prolonged Warm Ischemia Time: A Matched Comparison With Livers From Brain-Dead Donors.

Authors:  Damiano Patrono; Marinella Zanierato; Marco Vergano; Chiara Magaton; Enrico Diale; Giorgia Rizza; Silvia Catalano; Stefano Mirabella; Donatella Cocchis; Raffaele Potenza; Sergio Livigni; Roberto Balagna; Renato Romagnoli
Journal:  Transpl Int       Date:  2022-04-22       Impact factor: 3.842

Review 5.  Impact of Machine Perfusion on the Immune Response After Liver Transplantation - A Primary Treatment or Just a Delivery Tool.

Authors:  Rebecca Panconesi; Mauricio Flores Carvalho; Daniele Dondossola; Paolo Muiesan; Philipp Dutkowski; Andrea Schlegel
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

Review 6.  Mitochondria and Cancer Recurrence after Liver Transplantation-What Is the Benefit of Machine Perfusion?

Authors:  Alessandro Parente; Mauricio Flores Carvalho; Janina Eden; Philipp Dutkowski; Andrea Schlegel
Journal:  Int J Mol Sci       Date:  2022-08-28       Impact factor: 6.208

Review 7.  Machine Perfusion for Extended Criteria Donor Livers: What Challenges Remain?

Authors:  Jeannette Widmer; Janina Eden; Mauricio Flores Carvalho; Philipp Dutkowski; Andrea Schlegel
Journal:  J Clin Med       Date:  2022-09-03       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.